Keyphrases
1-methyl-4-phenylpyridinium
37%
Aconitase
12%
Anti-apoptotic
12%
Antioxidant Activity
25%
Apoptotic Cell Death
100%
Caspase-3 Activation
12%
Cell Death
25%
Clozapine
12%
Cytochrome c (Cyt c)
12%
Disease-modifying Effect
12%
Dopamine Agonist
12%
Dopamine Receptor
25%
Dopaminergic Mechanisms
100%
Dopaminergic Neurons
12%
Failure to Maintain
12%
Mitochondrial Membrane Potential
12%
Neuroprotective Action
12%
Neuroprotective Effect
12%
Non-dopaminergic
100%
Parkinson Patients
12%
Parkinson's Disease
12%
Potential-induced
12%
Pramipexole
100%
Pre-incubation
12%
Protective Effect
12%
Receptor Blockade
12%
Rotenone
37%
SH-SY5Y Cells
12%
Sulpiride
12%
Neuroscience
Aconitate Hydratase
12%
Antioxidant
25%
Apoptosis
100%
Caspase 3
12%
Cell Death
25%
Clozapine
12%
Cytochrome C
12%
Dopamine Agonist
12%
Dopamine Receptor
12%
Dopamine Receptor Blocking
12%
Dopaminergic
100%
Levosulpiride
12%
Mitochondrial Membrane Potential
12%
Neuroprotective Agent
25%
Parkinson's Disease
12%
Pramipexole
100%
Rotenone
37%
Sulpiride
12%
Treatment of Parkinson's Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
1 Methyl 4 Phenylpyridinium
37%
Aconitase
12%
Antiapoptotic
12%
Antioxidant Capacity
25%
Caspase 3
12%
Clozapine
12%
Cytochrome C
12%
Disease
12%
Dopamine Receptor
25%
Dopamine Receptor Stimulating Agent
100%
Neuroprotective Agent
25%
Parkinson's Disease
25%
Pramipexole
100%
Rotenone
37%
Sulpiride
12%